Markers of endothelial dysfunction after cardiac surgery: Soluble forms of vascular-1 and intercellular-1 adhesion molecules;Endotelio disfunkcijos žymenys po širdies operaciju: Tirpios kraujagyslių-1 ir tarpląstelinės sąveikos-1 adhezijos molekulės

Medicina

Volumn 45, Issue 6, 2009, Pages 434-439

  Balčiunas, Mindaugas ^a   Bagdonaite, Loreta ^a   Samalavičius, Robertas ^a   Baublys, Alis ^a  

^a VILNIUS UNIVERSITY   (Lithuania)

Author keywords

Adhesion molecules; Cardiac surgery; Endothelial dysfunction; Inflammation

Indexed keywords

EID: 70349578567     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.3390/medicina45060056     Document Type: Review

References (58)

1. Springer TA. Adhesion receptors of the immune system. Nature 1990;346:425-34.
2. Williams TJ, Hellewell PG. Endothelial cell biology. Am Rev Respir Dis 1992;146:S45-50.
3. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD. A form of circulating ICAM-1 in human serum. J Immunol 1991;147: 3788-93.
4. Ballantyne CE, Mainolfi JB, Young NT. Prognostic value of increased levels of circulating intercellular adhesion molecules-1 after heart transplantation. Clin Res 1992;39:285a.
5. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-12.
6. Ley K. Leukocyte adhesion to vascular endothelium. J Reconstr Microsurg 1992;8:495-503.
7. Rothlein R, Dustin ML, Martin SD. A human intercellular adhesion molecule (ICAM) distinct from LFA-1. J Immunol 1986;137:1270-5.
8. Elices MJ, Osborn L, Takada Y. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at the site distinct from the VLA-4/fibronectin binding site. Cell 1990;60:577-84.
9. Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998;105:S32-9.
10. Galley HF, Webster NR. Physiology of the endothelium. Br J Anaesth 2004;93:105-13.
11. Mann GE, Yudilevich DL, Sobrevia L. Regulation of amino acids and glucose transporters in endothelial and smooth muscle cells. Physiol Rev 2003;83:183-252.
12. Cines DB, Pollak ES, Buck CA. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527-61.
13. Sandset PM. Tissue factor pathway inhibitor (TFPI): an update. Haemostasis 1996;26(Suppl 4):154-65.
14. Sadler JE. Thrombomodulin structure and function. Thromb Haemost 1997;78:392-5.
15. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991;65:618-23.
16. Blann AD, McCollum CN, Lip GY. Relationship between plasma markers of endothelial cell integrity and the Framingham cardiovascular disease risk-factor scores in apparently healthy individuals. Blood Coagul Fibrinolysis 2002;13:513-8.
17. Kato H. Regulation of functions of vascular wall cells by tissue factor pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc Biol 2002;22:539-48.
18. Morange PE, Simon C, Alessi MC, Luc G, Arveiler D, Ferrieres J, et al. Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study. Circulation 2004;109: 1343-8.
19. Redl H, Schlag G, Marzi I. Leukocyte-endothelial interactions in trauma and sepsis. In: Lamy M, Thijs LG, editors. Mediators of sepsis: update in intensive care and emergency medicine. Vol. 16. New York: Springer; 1992. p. 125-35.
20. Mariscalco MM. Leukocytes and the inflammatory response. Crit Care Med 1993;21:S347-9.
21. Stoolman LM. Adhesion molecules involved in leukocyte recruitment and lymphocyte recirculation. Chest 1993;103 (Suppl):S79-86.
22. Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: distinction from prerequisite for adhesion through integrins. Cell 1991;65:1-20.
23. Root RK. Leukocyte adhesion proteins: their role in neutrophil function. Trans Am Climatol Assoc 1989;101:207-24.
24. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000;101:1899-906.
25. Suwaidi JA, Hamasaki S, Higano ST. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 2000;101:948-54.
26. Mering GO, Pepine CJ, McGorray SP. Abnormal coronary vasomotion in response to acetylcholine predicts increased cardiac events in woman: data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 2001;37:243A.
27. Morariu AM, Gu YJ. Red blood cell aggregation during cardiopulmonary bypass: a pathogenic cofactor in endothelial cell activation? E J Cardio-thorac Surg 2004;26:939-46.
28. Oudemans-van Straaten HM, Jansen PG, Hoek FJ, Deventer SJ, Sturk A, Stoutenbeek CP, et al. Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth 1996; 10:87-194.
29. Marcus AJ. Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. Semin Hematol 1994;31: 261-9.
30. Gillinov AM, Bator JM, Zehr KJ, Redmond JM, Burch RM, Ko C. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Ann Thorac Surg 1993; 56:847-53.
31. Cremer J, Martin M, Redl H, Bahrami S, Abraham C, Graeter T, et al. Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 1996;61: 1714-20.
32. Leclerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg 1997;63: 269-76
33. Boldt J, Kumle B, Papsdorf M. Are circulating adhesion molecules specifically changed in cardiac surgical patients? Ann Thorac Surg 1998;65:608-14.
34. Blume ED, Nelson DP, Gauvreau K. Soluble adhesion molecules in infants and children undergoing cardiopulmonary bypass. Circulation 1997;96:II-352-7.
35. Balčiūnas M, Bagdonaitė L, Baublys A, Griškevičius L. Perioperacinės endotelio funkcijos itaka kardiovaskulinėms komplikacijoms rastis po širdies vainikiniu{ogonek} arteriju{ogonek} apeinamu{ogonek}ju{ogonek} jungčiu{ogonek} operacijos su dirbtine kraujo apytaka. (Impact of perioperative endothelial dysfunction on cardiovascular complications after coronary artery bypass grafting with cardiopulmonary bypass.) Laboratorinė medicina 2007;9(4):180-5.
36. Grünenfelder J, Zünd G, Schoeberlein A, Schurr U, Frisullo R, Schimd ER, et al. Expression of adhesion molecules and cytokines after coronary artery bypass grafting during normothermic and hypothermic cardiac arrest. Eur J Cardiothorac Surg 2000;17:723-8.
37. Wei M, Kuukasjärvi P, Laurikka J, Kaukinen S, Iisalo P, Laine S, et al. Soluble adhesion molecules and myocardial injury during coronary artery bypass grafting. World J Surg 2003; 27(2):140-4.
38. Appleyard RF, Cohn LH. Myocardial stunning and reperfusion injury in cardiac surgery. J Card Surg 1993;8(2 Suppl):316-24.
39. Suzuki T, Ito T, Kashima I, Teruya K, Fukuda T. Continuous perfusion of pulmonary arteries during total cardiopulmonary bypass favorably affects levels of circulating adhesion molecules and lung function. J Thorac Cardiovasc Surg 2001; 122(2):242-8.
40. Chello M, Carassiti M, Agrò F, Mastroroberto P, Pugliese G, Colonna D, et al. Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2004; 18(5):605-9.
41. Kilbridge PM, Mayer JE, Newburger JW, Hickey PR, Walsh AZ, Neufeld EJ. Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107:1183-92.
42. Entman ML, Youker K, Shoij T, Kukielka G, Shappell SB, Taylor AA, et al. Neutrophil induced oxidative injury of cardiac myocytes: a compartmented system requiring CD11b/ CD18-ICAM-1 adherence. J Clin Invest 1992;90:1335-45.
43. Boldt J, Wollbruck M, Kuhn D, Linke LC, Hempelmann G. Do plasma levels of circulating soluble adhesion molecules differ between surviving and nonsurviving critically ill patients? Chest 1995;107:787-92.
44. Cowley HC, Heney D, Gearing AJH. Increased circulating adhesion molecule concentrations in patients with septic inflammatory response: a prospective cohort study. Crit Care Med 1994;22:651-7.
45. Donnelly SC, Haslett C, Dransfield I. Circulating soluble selectin adhesion molecules and the development of the adult respiratory distress syndrome (ARDS) in at-risk patients groups. Intensive Care Med 1994;20(Suppl 1):S89.
46. Kalawski R, Balinski M, Bugajski P. Stimulation of neutrophil activation during coronary artery bypass grafting: comparison of crystalloid and blood cardioplegia. Ann Thorac Surg 2001;71:827-31.
47. Siminiak T, Smielecki J, Dye JF, Baliñski M, El-Gendi H, Wysocki H. Increased release of the soluble form of the adhesion molecules L-selectin and ICAM-1 but not E-selectin during attacks of angina pectoris. Heart Vessels 1998;13:189-94.
48. Kalawski R, Bugajski P, Smielecki J. Soluble adhesion molecules in reperfusion during coronary bypass grafting. Eur J Cardiothorac Surg 1998;14:290-5.
49. Siminiak T, Flores NA, Sheridan DJ. Neutrophil interactions with endothelium and platelets: possible role in development of cardiovascular injury. Eur Heart J 1995;16:160-70.
50. Valen G, Paulsson G, Vaage J. Induction of inflammatory mediators during reperfusion of the human heart. Ann Thorac Surg 2001;71:226-32.
51. Kalawski R, Majewski M, Kaszkowiak E, Wysocki H, Siminiak T. Transcardiac release of soluble adhesion molecules during coronary artery bypass grafting: effects of crystalloid and blood cardioplegia. Chest 2003;123:1355-60.
52. Boldt J, Osmer Ch, Linke LC, Dapper F, Hempelmann G. Circulating adhesion molecules in pediatric cardiac surgery. Anesth Analg 1995;81:1129-35.
53. McEver RP. Leukocyte interactions mediated by selectins. Thromb Haemost 1991;66:80-7.
54. Chaudry IH, Ayala A. Immune consequences of hypovolemic shock and resuscitation. Curr Opin Anesth 1993;6:385-92.
55. Wei M, Laurikka J, Kuukasjärvi P, Pehkonen E, Tarkka M. Soluble adhesion molecules in coronary artery bypass surgery: Asian Cardiovasc Thorac Ann 2003;11(3):198-202.
56. Görlach G, Sroka J, Heidt M, Knez I, Sablotzki A, Schönburg M, et al. Intracellular adhesion molecule-1 in patients developing pulmonary insufficiency after cardiopulmonary bypass. Thorac Cardiovasc Surg 2003;51(3):138-41.
57. Zünd G, Dzus AL, Prêtre R, Niederhäuser U, Vogt P, Turina M. Endothelial cell injury in cardiac surgery: salicylate may be protective by reducing expression of endothelial adhesion molecules. Eur J Cardiothorac Surg 1998;13:293-7.
58. Gillinov AM, De Valeria PA, Winkelstein JA, Wilson I, Curtis WE, Shaw D, et al. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. Ann Thorac Surg 1993;55:619-24